Formulating for the GLP-1 Consumer – IFF Ingredients lead the way

The rise of GLP-1 medications like Ozempic and Wegovy is reshaping more than weight loss, it's redefining how millions of consumers experience food. The shift is clear: appetite, taste perception, and nutritional needs are fundamentally changing.

GLP-1 users eat less but need more from every bite.  They are looking for more protein, fiber, hydration, and micronutrients delivered in smaller, gentler, more satisfying formats. Formulation is critical. Products must modulate taste (especially sweetness and bitterness), improve texture for dry mouth and digestive sensitivity, and deliver real nutrition in compact, craveable ways. Equally important is shifting messaging from “low-calorie” and “guilt-free” to “nutrient-packed” and “supportive.”

With 85% of GLP-1 consumers reporting significant changes in taste and food experience, the need for new formulations is urgent. That’s where IFF’s science-driven solutions come in.

IFF is pioneering ingredient solutions that make eating enjoyable again, with a portfolio purpose-built for GLP-1 consumers:

• SUPRO® Premium Soy Protein: Delivers complete, high-quality protein with excellent digestibility — ideal for maintaining muscle mass in a smaller portion.

• LITESSE® ULTRA™ Prebiotic Fiber: Supports gut health and satiety, without adding bulk or bloating.

• TAURA Fruit Pastes & Pieces: Add natural sweetness, texture contrast and nutritional value in compact formats.

 Whether you're creating a new functional beverage, optimizing a protein bar, or reimagining a legacy snack, IFF and SPI Group are your formulation partners. We’re here to help you deliver products that are not only compatible with GLP-1 user needs but also lead in taste, nutrition, and satisfaction.

Reach out to SPI Group today for guidance on ingredient selection and formulation strategy as you navigate the next wave of product innovation for the GLP-1 consumer.